Finally, further large-scale cohort studies, including the projective analysis of potential PD patients over time, is needed to provide more definitive evidence that AIMP2 and parkin could be valuable biomarkers for early PD diagnosis. The gene discussed is AIMP2; the disease is Parkinson disease.